Name: Zoladex Market Size, Share, Industry, Forecast and outlook (2023-2030)
Brand: DataM Intelligence
SKU: PH4245
Price: 4350 USD
Availability: InStock

Zoladex Market Size Share Growth Opportunities and Forecast 2022

Zoladex Market Size, Share, Industry, Forecast and outlook (2023-2030)

<h2>Global Zoladex Market is Segmented By Dosage (3.6 mg, 10.8 mg), By Application(Prostate Cancer, Breast Cancer, Endometriosis, Others), By Distribution Channel(Hospital Pharmacy,&nbsp;Retail Pharmacy, Online Pharmacy), and By Region (North America, Latin America, Europe, Asia Pacific, Middle East, and Africa) &ndash; Share, Size, Outlook, and Opportunity Analysis, &nbsp;2023-2030</h2>

<h2>&nbsp;</h2>

<h3>Market Overview</h3>

<blockquote>
The global zoladex market reached US$ 0.92 billion in 2022 and is expected to reach US$ 1.03 &nbsp;billion by 2030 growing with a CAGR of 1.4% during the forecast period 2023-2030. The zoladex market trends show rising demand for treatment options for breast or prostate cancer. ​
</blockquote>

Furthermore, steady growth, driven by a combination of continuous technological advancements, growing environmental awareness, and the rising need for streamlined operations will drive the zoladex market size. The market is experiencing a growth demand for products from North American areas as a result of the rising advancements in this field with significant competitors like AstraZeneca, Mithra Pharmaceuticals, Alvogen Inc. actively operating in the market.

<h3>Scope</h3>

<table cellspacing="0" style="border-collapse:collapse">
	<tbody>
		<tr>
			<td style="background-color:#4472c4; border-bottom:1px solid #4472c4; border-left:1px solid #4472c4; border-right:1px solid #8eaadb; border-top:1px solid #4472c4; vertical-align:top; width:312px">
			Metrics
			</td>
			<td style="background-color:#4472c4; border-bottom:1px solid #4472c4; border-left:1px solid #8eaadb; border-right:1px solid #4472c4; border-top:1px solid #4472c4; vertical-align:top; width:312px">
			Details
			</td>
		</tr>
		<tr>
			<td style="background-color:#d9e2f3; border-bottom:1px solid #8eaadb; border-left:1px solid #8eaadb; border-right:1px solid #8eaadb; border-top:1px solid #4472c4; vertical-align:middle; width:312px">
			CAGR
			</td>
			<td style="background-color:#d9e2f3; border-bottom:1px solid #8eaadb; border-left:1px solid #8eaadb; border-right:1px solid #8eaadb; border-top:1px solid #4472c4; vertical-align:middle; width:312px">
			1.4%
			</td>
		</tr>
		<tr>
			<td style="background-color:#d6e6f4; border-bottom:1px solid #8eaadb; border-left:1px solid #8eaadb; border-right:1px solid #8eaadb; border-top:1px solid #8eaadb; vertical-align:middle; width:312px">
			Size Available for Years
			</td>
			<td style="background-color:#d6e6f4; border-bottom:1px solid #8eaadb; border-left:1px solid #8eaadb; border-right:1px solid #8eaadb; border-top:1px solid #8eaadb; vertical-align:middle; width:312px">
			2021-2030
			</td>
		</tr>
		<tr>
			<td style="background-color:#d9e2f3; border-bottom:1px solid #8eaadb; border-left:1px solid #8eaadb; border-right:1px solid #8eaadb; border-top:1px solid #8eaadb; vertical-align:middle; width:312px">
			Forecast Period
			</td>
			<td style="background-color:#d9e2f3; border-bottom:1px solid #8eaadb; border-left:1px solid #8eaadb; border-right:1px solid #8eaadb; border-top:1px solid #8eaadb; vertical-align:middle; width:312px">
			2023-2030
			</td>
		</tr>
		<tr>
			<td style="background-color:#d6e6f4; border-bottom:1px solid #8eaadb; border-left:1px solid #8eaadb; border-right:1px solid #8eaadb; border-top:1px solid #8eaadb; vertical-align:middle; width:312px">
			Data Availability
			</td>
			<td style="background-color:#d6e6f4; border-bottom:1px solid #8eaadb; border-left:1px solid #8eaadb; border-right:1px solid #8eaadb; border-top:1px solid #8eaadb; vertical-align:middle; width:312px">
			Value (US$)
			</td>
		</tr>
		<tr>
			<td style="background-color:#d9e2f3; border-bottom:1px solid #8eaadb; border-left:1px solid #8eaadb; border-right:1px solid #8eaadb; border-top:1px solid #8eaadb; vertical-align:middle; width:312px">
			Segments Covered
			</td>
			<td style="background-color:#d9e2f3; border-bottom:1px solid #8eaadb; border-left:1px solid #8eaadb; border-right:1px solid #8eaadb; border-top:1px solid #8eaadb; vertical-align:middle; width:312px">
			Dosage, Application,&nbsp;Distribution Channel
			</td>
		</tr>
		<tr>
			<td style="background-color:#d6e6f4; border-bottom:1px solid #8eaadb; border-left:1px solid #8eaadb; border-right:1px solid #8eaadb; border-top:1px solid #8eaadb; vertical-align:middle; width:312px">
			Regions Covered
			</td>
			<td style="background-color:#d6e6f4; border-bottom:1px solid #8eaadb; border-left:1px solid #8eaadb; border-right:1px solid #8eaadb; border-top:1px solid #8eaadb; vertical-align:middle; width:312px">
			North America, Europe, Asia-Pacific, South America and Middle East &amp; Africa
			</td>
		</tr>
		<tr>
			<td style="background-color:#d9e2f3; border-bottom:1px solid #8eaadb; border-left:1px solid #8eaadb; border-right:1px solid #8eaadb; border-top:1px solid #8eaadb; vertical-align:middle; width:312px">
			Fastest Growing Region
			</td>
			<td style="background-color:#d9e2f3; border-bottom:1px solid #8eaadb; border-left:1px solid #8eaadb; border-right:1px solid #8eaadb; border-top:1px solid #8eaadb; vertical-align:middle; width:312px">
			Asia-Pacific
			</td>
		</tr>
		<tr>
			<td style="background-color:#d6e6f4; border-bottom:1px solid #8eaadb; border-left:1px solid #8eaadb; border-right:1px solid #8eaadb; border-top:1px solid #8eaadb; vertical-align:middle; width:312px">
			Largest Region
			</td>
			<td style="background-color:#d6e6f4; border-bottom:1px solid #8eaadb; border-left:1px solid #8eaadb; border-right:1px solid #8eaadb; border-top:1px solid #8eaadb; vertical-align:middle; width:312px">
			North America
			</td>
		</tr>
		<tr>
			<td style="background-color:#d9e2f3; border-bottom:1px solid #8eaadb; border-left:1px solid #8eaadb; border-right:1px solid #8eaadb; border-top:1px solid #8eaadb; vertical-align:middle; width:312px">
			Report Insights Covered
			</td>
			<td style="background-color:#d9e2f3; border-bottom:1px solid #8eaadb; border-left:1px solid #8eaadb; border-right:1px solid #8eaadb; border-top:1px solid #8eaadb; vertical-align:middle; width:312px">
			Competitive Landscape Analysis, Company Profile Analysis, Market Size, Share, Growth, Demand, Recent Developments, Mergers and Acquisitions, New Product Launches, Growth Strategies, Revenue Analysis, Porter&rsquo;s Analysis, Pricing Analysis, Regulatory Analysis, Supply-Chain Analysis and Other key Insights.
			</td>
		</tr>
	</tbody>
</table>

&nbsp;

For More Insights about the Market <a href="https://www.datamintelligence.com/download-sample/zoladex-market" target="_blank">Request Free Sample</a>

&nbsp;

<h3>Market Dynamics</h3>

Increasing Prevalence of Breast Cancer Associated with Infertility due to Chemotherapy Drive the Growth of the Zoladex Market

The rising cases of breast cancer related to infertility caused owing to chemotherapy along with several research studies are driving the zoladex market&rsquo;s growth. Based on the stage of the tumour, chemotherapy is a common form of treatment for breast cancer patients. Chemotherapy increases the risk of infertility. In addition, the age of the patient as well as the kinds and dosages of the chemotherapy drugs the patient is taking affect fertility following chemotherapy.&nbsp;

The best probability of getting pregnant following chemotherapy is for cancer patients under the age of 30. In general, a woman&#39;s chances of having viable eggs following chemotherapy increase with age. Additionally, some chemotherapy drugs, such as Cytoxan (cyclophosphamide), are more likely than others to result in infertility. According to a study, premenopausal women with early-stage, hormone-receptor-negative breast cancer who received Zoladex treatment along with chemotherapy before having their cancer surgically removed had a significantly lower risk of becoming infertile later on.

Rising Advancements or Research and Development by Key Players Creates Opportunities for the Growth of the Market

Goserelin acetate is the active ingredient in the experimental novel medication LY01005, which is designed for intramuscular injection&nbsp;as extended-release microspheres. Pharmacodynamics, pharmacokinetics, and toxicology tests on rats were carried out to support the suggested clinical trials or marketing application of LY01005. In the pharmacological investigation in rats, LY01005 first increased testosterone levels above physiological levels at 24 hours after administration, but these levels thereafter quickly decreased to castration levels.&nbsp;

LY01005&#39;s potency was comparable to that of the Zoladex comparison, but it had a more enduring and steady impact. Nearly all of the positive results of LY01005 in the toxicity study on rats, including changes in hormones (FSH, LH, testosterone, and progestin) and reproductive system (vagina, ovary, uterus,&nbsp;cervix uteri, testis, mammary gland, prostate and&nbsp;epididymis), were linked to the&nbsp;pharmacological effects of goserelin. These research and advancements will lead to growth of more treatment options for breast or prostate cancer.

Side Effects of the Zoladex Implant will hamper the growth of the market

Several side effects are associated with the Zoladex injection. It is possible to experience hot flashes (flushing), headaches, dizziness, increased perspiration, decreased sexual interest or ability, difficulties sleeping, nausea, a change in breast size, dryness in the vagina, or hair loss. There may also be pain, bleeding,&nbsp;bruising, redness, or inflammation where the injection was given. Rarely, this medicine may induce a spike in blood sugar, which can lead to or exacerbate diabetes.

For more details on this report &ndash; <a href="https://www.datamintelligence.com/download-sample/zoladex-market">Download Sample</a>

<h3>&nbsp;</h3>

<h3>Segment Analysis</h3>

The global zoladex market is segmented based on dosage, application, distribution channel and region.

Owing to High Utilization, the 3.6 mg from Dosage Segment Accounted for Approximately 55.6% of the Zoladex Market Share

The 3.6 mg category held the largest market share in 2022 and is expected to maintain its dominance over the forecast period due to a growth in breast cancer incidence worldwide, amongst the population. The 3.6 mg implant is used for endometriosis that has been visually proven, to reduce symptoms and the amount of endometrial lesions, for uterine fibroids, to shrink lesions while decreasing symptoms, for advanced breast cancer treatment in premenopausal women&nbsp;and for adjuvant treatment of early-stage breast cancer, in which hormonal manipulation is appropriate.&nbsp;

Every 28 days, one implant must be subcutaneously inserted into the front abdominal wall in men with prostate cancer. A delayed injection may result in an increase in testosterone levels. In case of females, one implant ought to be injected subcutaneously onto the anterior abdomen wall every 28 days, and treatment should last for two to five years when zoladex is employed as a substitute to combination chemotherapy in early breast cancer.

<img src="https://lh6.googleusercontent.com/zcR0Bk8FtbqQMFVzO1m8SzUddKRLUSXqaRpDgDL_01_pkpr_IkB5UMqHko6gzungr-4UA4tmwoi6iPYObo07wF7lax7cvZK8sIllQbwqGEeMj6zc11KAVDahCjOaa8JaZPYW9KDAJGChqkEgHq6nIg" style="height:336px; width:576px" />

Source: DataM Intelligence Analysis (2023)

<h2>&nbsp;</h2>

<h3>Geographical Penetration</h3>

North America Accounted for Approximately 40.3% of the Market Share in 2022, Owing to the Strong Presence of Major Players and Increasing Healthcare Infrastructure Investment

Due to the rising need for zoladex for treatment purpose in healthcare, manufacturers in North America have chances of increasing their operations. There are several producers and suppliers in North America and owing to the quick economic growth of the region, industrial production has expanded, driving the demand for zoladex treatment. Increasing expenditure on healthcare and rising utilization among end users for cancer treatment, advancement of technologies for administration via different routes, and increase in pharmaceutical business establishment across the region are also contributing to the growth of zoladex market share of this region.&nbsp;

It is also anticipated that the main healthcare organizations&#39; and enterprises&#39; strategic initiatives or research projects along with innovative product development, which constantly seeks to enhance the available medications alternatives, will contribute to the expanding demand. The above-mentioned factors further proves the dominance of North America on a global scale.

<img src="https://lh3.googleusercontent.com/aTH0MGf343Ar0dGOObx8L5XtnOA-e_WVu3DNR_8KtkOrYXShvGJgHQ05DRFwnOia2OKJm1h10h3_nWgtd0GhOcQGTAQCDWSXbazuDaPD4aV3tl0qaYcLC68XoQxK7C7bR5QOenqrpNeY4IBgIkFaFA" style="height:336px; width:576px" />

Source: DataM Intelligence Analysis (2023)

<h2>&nbsp;</h2>

<h3>Major Key Players</h3>

The major global players in the zoladex market include Tersera Therapeutics, Mithra Pharmaceuticals, Alvogen, AMW GmbH, AstraZeneca, Luye Pharma, Atossa Therapeutics, Sanofi, Fosun Pharma and Bachem among others.

&nbsp;

COVID-19 Impact Analysis

Russia-Ukraine Conflict Analysis

Due to the low prevalence as well as absence of major market participants in this region, it is predicted that the Russia-Ukraine conflict will not have a significant effect on the worldwide zoladex market. The growth of the global zoladex market, however, is anticipated to be relatively unaffected by the import and export of raw materials over the forecast period.

By Dosage

<ul>
	<li>3.6 mg&nbsp;</li>
	<li>10.8 mg</li>
</ul>

By Application

<ul>
	<li>Prostate Cancer&nbsp;</li>
	<li>Breast Cancer</li>
	<li>Endometriosis</li>
	<li>Others</li>
</ul>

By Distribution Channel

<ul>
	<li>Hospital Pharmacy</li>
	<li>Retail Pharmacy</li>
	<li>Online Pharmacy</li>
</ul>

By Region

<ul>
	<li>North America
	<ul>
		<li>U.S.</li>
		<li>Canada</li>
		<li>Mexico</li>
	</ul>
	</li>
	<li>Europe
	<ul>
		<li>Germany</li>
		<li>U.K.</li>
		<li>France</li>
		<li>Spain</li>
		<li>Italy</li>
		<li>Rest of Europe</li>
	</ul>
	</li>
	<li>South America
	<ul>
		<li>Brazil</li>
		<li>Argentina</li>
		<li>Rest of South America</li>
	</ul>
	</li>
	<li>Asia-Pacific
	<ul>
		<li>China</li>
		<li>India</li>
		<li>Japan</li>
		<li>Australia</li>
		<li>Rest of Asia-Pacific</li>
	</ul>
	</li>
	<li>Middle East and Africa</li>
</ul>

<h2>Key Developments</h2>

<ul>
	<li>On June 30, 2021, a long-term investment fund with a pharmaceuticals concentration is Aztiq Pharma Partners whose&nbsp;goal is to make it easier for patients to acquire high-quality, cheap medications&nbsp; announced that it was successful in raising $100 million in financing to buy freshly issued shares of Alvogen US. Aztiq used the funds to purchase a 17% share in Alvogen US at a pre-money valuation of US$350 million from Fora.</li>
	<li>On June 24, 2021, the firm Mithra, which focuses on women&#39;s health, is happy to report that it was able to successfully renegotiate the earnouts associated with two of the medicines in its Complex Therapeutic product&nbsp;portfolio including the Myring hormonal contraceptive ring and&nbsp;the Zoreline implant. A biodegradable&nbsp;implant called Zoreline administered subcutaneously&nbsp;is used to treat breast cancer, prostate cancer, and benign gynecological conditions such endometriosis and uterine fibroids.&nbsp;</li>
	<li>On July, 29, 2022, in a study done on premenopausal individuals who tested positive for ER, the European Society for Medical Oncology reported that 2 years of adjuvant endocrine therapy had a 20-year benefit. Premenopausal individuals with oestrogen receptor (ER)-positive breast cancer in the Stockholm portion of the Zoladex in Premenopausal individuals study (STO-5) show a substantial 20-year advantage after 2 years of tamoxifen,&nbsp;goserelin, and the combination, relative to&nbsp;no adjuvant endocrine treatment. Additionally, the study contends that goserelin benefits genomic high-risk patients early while tamoxifen benefits genomic low-risk patients significantly over the long term.</li>
</ul>

Why Purchase the Report?

<ul>
	<li>To visualize the global zoladex market segmentation based on dosage, application, distribution channel and region, as well as understand key commercial assets and players.</li>
	<li>Identify commercial opportunities by analyzing trends and co-development.&nbsp;</li>
	<li>Excel data sheet with numerous data points of zoladex market-level with all segments.</li>
	<li>PDF report consists of a comprehensive analysis after exhaustive qualitative interviews and an in-depth study.</li>
	<li>Product mapping available as excel consisting of key products of all the major players.</li>
</ul>

The global zoladex market report would provide approximately 53 tables, 54 figures and 195 Pages.

Target Audience 2023

<ul>
	<li>Manufacturers/ Buyers</li>
	<li>Industry Investors/Investment Bankers</li>
	<li>Research Professionals</li>
	<li>Emerging Companies</li>
</ul>

<ol>
	<li>
	<h3>Methodology and Scope</h3>

	<ol>
		<li>Research Methodology</li>
		<li>Research Objective and Scope of the Report</li>
	</ol>
	</li>
	<li>
	<h3>Definition and Overview</h3>
	</li>
	<li>
	<h3>Executive Summary</h3>

	<ol>
		<li>Snippet by Dosage</li>
		<li>Snippet by Application</li>
		<li>Snippet by Distribution Channel</li>
		<li>Snippet by Region</li>
	</ol>
	</li>
	<li>
	<h3>Dynamics</h3>

	<ol>
		<li>Impacting Factors
		<ol>
			<li>Drivers
			<ol>
				<li>Increasing Prevalence of Breast Cancer Associated with Infertility due to Chemotherapy</li>
				<li>Rising Demands for Prostate Cancer Treatment &nbsp;</li>
			</ol>
			</li>
			<li>Restraints
			<ol>
				<li>Side Effects of the Zoladex Implant</li>
			</ol>
			</li>
			<li>Opportunity
			<ol>
				<li>
				<ol>
					<li>Rising Advancements or Research and Development &nbsp;by Key Players</li>
				</ol>
				</li>
			</ol>
			</li>
			<li>Impact Analysis</li>
		</ol>
		</li>
	</ol>
	</li>
	<li>
	<h3>Industry Analysis</h3>

	<ol>
		<li>Porter&rsquo;s Five Forces Analysis &nbsp;</li>
		<li>Supply Chain Analysis</li>
		<li>Pricing Analysis</li>
		<li>Regulatory Analysis</li>
		<li>COVID-19 Analysis</li>
	</ol>
	</li>
	<li>
	<h3>Analysis of COVID-19</h3>

	<ol>
		<li>
		<ol>
			<li>Scenario Before COVID-19</li>
			<li>Scenario During COVID-19</li>
			<li>Scenario Post COVID-19</li>
		</ol>
		</li>
		<li>Pricing Dynamics Amid COVID-19</li>
		<li>Demand-Supply Spectrum</li>
		<li>Government Initiatives Related to the Market During Pandemic</li>
		<li>Manufacturers Strategic Initiatives</li>
		<li>Conclusion</li>
	</ol>
	</li>
	<li>
	<h3>By Dosage</h3>

	<ol>
		<li>Introduction
		<ol>
			<li>Market Size Analysis and Y-o-Y Growth Analysis (%), By Dosage</li>
			<li>Market Attractiveness Index, By Dosage</li>
		</ol>
		</li>
		<li>3.6 mg *
		<ol>
			<li>Introduction</li>
			<li>Market Size Analysis and Y-o-Y Growth Analysis (%)</li>
		</ol>
		</li>
		<li>10.8 mg</li>
	</ol>
	</li>
	<li>
	<h3>By Application</h3>

	<ol>
		<li>Introduction
		<ol>
			<li>Market Size Analysis and Y-o-Y Growth Analysis (%), By Application</li>
			<li>Market Attractiveness Index, By Application</li>
		</ol>
		</li>
		<li>Prostate Cancer *
		<ol>
			<li>Introduction</li>
			<li>Market Size Analysis and Y-o-Y Growth Analysis (%)</li>
		</ol>
		</li>
		<li>Breast Cancer</li>
		<li>Endometriosis</li>
		<li>Others</li>
	</ol>
	</li>
	<li>
	<h3>By Distribution Channel</h3>

	<ol>
		<li>Introduction
		<ol>
			<li>Market Size Analysis and Y-o-Y Growth Analysis (%), By Distribution Channel</li>
			<li>Market Attractiveness Index, By Distribution Channel</li>
		</ol>
		</li>
		<li>Hospital Pharmacy*
		<ol>
			<li>Introduction</li>
			<li>Market Size Analysis and Y-o-Y Growth Analysis (%)</li>
		</ol>
		</li>
		<li>Retail Pharmacy</li>
		<li>Online Pharmacy</li>
	</ol>
	</li>
	<li>
	<h3>By Region</h3>

	<ol>
		<li>Introduction
		<ol>
			<li>Market Size Analysis and Y-o-Y Growth Analysis (%), By Region</li>
			<li>Market Attractiveness Index, By Region</li>
		</ol>
		</li>
		<li>North America
		<ol>
			<li>Introduction</li>
			<li>Key Region-Specific Dynamics</li>
			<li>Market Size Analysis and Y-o-Y Growth Analysis (%), By Dosage</li>
			<li>Market Size Analysis and Y-o-Y Growth Analysis (%), By Application</li>
			<li>Market Size Analysis and Y-o-Y Growth Analysis (%), By Distribution Channel</li>
			<li>Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
			<ol>
				<li>U.S.</li>
				<li>Canada</li>
				<li>Mexico</li>
			</ol>
			</li>
		</ol>
		</li>
		<li>Europe
		<ol>
			<li>Introduction</li>
			<li>Key Region-Specific Dynamics</li>
			<li>Market Size Analysis and Y-o-Y Growth Analysis (%), By Dosage</li>
			<li>Market Size Analysis and Y-o-Y Growth Analysis (%), By Application</li>
			<li>Market Size Analysis and Y-o-Y Growth Analysis (%), By Distribution Channel</li>
			<li>Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
			<ol>
				<li>Germany</li>
				<li>U.K.</li>
				<li>France</li>
				<li>Spain</li>
				<li>Italy</li>
				<li>Rest of Europe</li>
			</ol>
			</li>
		</ol>
		</li>
		<li>South America
		<ol>
			<li>Introduction</li>
			<li>Key Region-Specific Dynamics</li>
			<li>Market Size Analysis and Y-o-Y Growth Analysis (%), By Dosage</li>
			<li>Market Size Analysis and Y-o-Y Growth Analysis (%), By Application</li>
			<li>Market Size Analysis and Y-o-Y Growth Analysis (%), By Distribution Channel</li>
			<li>Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
			<ol>
				<li>Brazil</li>
				<li>Argentina</li>
				<li>Rest of South America</li>
			</ol>
			</li>
		</ol>
		</li>
		<li>Asia-Pacific
		<ol>
			<li>Introduction</li>
			<li>Key Region-Specific Dynamics</li>
			<li>Market Size Analysis and Y-o-Y Growth Analysis (%), By Dosage</li>
			<li>Market Size Analysis and Y-o-Y Growth Analysis (%), By Application</li>
			<li>Market Size Analysis and Y-o-Y Growth Analysis (%), By Distribution Channel</li>
			<li>Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
			<ol>
				<li>China</li>
				<li>India</li>
				<li>Japan</li>
				<li>Australia</li>
				<li>Rest of Asia-Pacific</li>
			</ol>
			</li>
		</ol>
		</li>
		<li>Middle East and Africa
		<ol>
			<li>Introduction</li>
			<li>Key Region-Specific Dynamics</li>
			<li>Market Size Analysis and Y-o-Y Growth Analysis (%), By Dosage</li>
			<li>Market Size Analysis and Y-o-Y Growth Analysis (%), By Application</li>
			<li>Market Size Analysis and Y-o-Y Growth Analysis (%), By Distribution Channel</li>
		</ol>
		</li>
	</ol>
	</li>
	<li>
	<h3>Competitive Landscape</h3>

	<ol>
		<li>Competitive Scenario</li>
		<li>Market Positioning/Share Analysis</li>
		<li>Mergers and Acquisitions Analysis</li>
	</ol>
	</li>
	<li>
	<h3>Company Profiles</h3>

	<ol>
		<li>AstraZeneca *
		<ol>
			<li>Company Overview</li>
			<li>Product Portfolio and Description</li>
			<li>Financial Overview</li>
			<li>Key Developments</li>
		</ol>
		</li>
		<li>TerSera Therapeutics LLC</li>
		<li>Mithra Pharmaceuticals</li>
		<li>Alvogen Inc.</li>
		<li>AMW GmbH</li>
		<li>Luye Pharma</li>
		<li>Atossa Therapeutics</li>
		<li>Sanofi</li>
		<li>Fosun Pharma</li>
		<li>Bachem (*LIST NOT EXHAUSTIVE) </li>
	</ol>
	</li>
	<li>
	<h3>Appendix</h3>

	<ol>
		<li>About Us and Endometriosis</li>
		<li>Contact Us</li>
	</ol>
	</li>
</ol>

<h3>List of Tables</h3>

Table 1 Global Zoladex Market Value, By Dosage, 2022, 2026 &amp; 2030 (US$ Million)

Table 2 Global Zoladex Market Value, By Application, 2022, 2026 &amp; 2030 (US$ Million)

Table 3 Global Zoladex Market Value, By Distribution Channel, 2022, 2026 &amp; 2030 (US$ Million)

Table 4 Global Zoladex Market Value, By Region, 2022, 2026 &amp; 2030 (US$ Million)

Table 5 Global Zoladex Market Value, By Dosage, 2022, 2026 &amp; 2030 (US$ Million)

Table 6 Global Zoladex Market Value, By Dosage, 2021-2030 (US$ Million)

Table 7 Global Zoladex Market Value, By Application, 2022, 2026 &amp; 2030 (US$ Million)

Table 8 Global Zoladex Market Value, By Application, 2021-2030 (US$ Million)

Table 9 Global Zoladex Market Value, By Distribution Channel, 2022, 2026 &amp; 2030 (US$ Million)

Table 10 Global Zoladex Market Value, By Distribution Channel, 2021-2030 (US$ Million)

Table 11 Global Zoladex Market Value, By Region, 2022, 2026 &amp; 2030 (US$ Million)

Table 12 Global Zoladex Market Value, By Region, 2021-2030 (US$ Million)

Table 13 North America Zoladex Market Value, By Dosage, 2021-2030 (US$ Million)

Table 14 North America Zoladex Market Value, By Application, 2021-2030 (US$ Million)

Table 15 North America Zoladex Market Value, By Distribution Channel, 2021-2030 (US$ Million)

Table 16 North America Zoladex Market Value, By Country, 2021-2030 (US$ Million)

Table 17 South America Zoladex Market Value, By Dosage, 2021-2030 (US$ Million)

Table 18 South America Zoladex Market Value, By Application, 2021-2030 (US$ Million)

Table 19 South America Zoladex Market Value, By Distribution Channel, 2021-2030 (US$ Million)

Table 20 South America Zoladex Market Value, By Country, 2021-2030 (US$ Million)

Table 21 Europe Zoladex Market Value, By Dosage, 2021-2030 (US$ Million)

Table 22 Europe Zoladex Market Value, By Application, 2021-2030 (US$ Million)

Table 23 Europe Zoladex Market Value, By Distribution Channel, 2021-2030 (US$ Million)

Table 24 Europe Zoladex Market Value, By Country, 2021-2030 (US$ Million)

Table 25 Asia-Pacific Zoladex Market Value, By Dosage, 2021-2030 (US$ Million)

Table 26 Asia-Pacific Zoladex Market Value, By Application, 2021-2030 (US$ Million)

Table 27 Asia-Pacific Zoladex Market Value, By Distribution Channel, 2021-2030 (US$ Million)

Table 28 Asia-Pacific Zoladex Market Value, By Country, 2021-2030 (US$ Million)

Table 29 Middle East &amp; Africa Zoladex Market Value, By Dosage, 2021-2030 (US$ Million)

Table 30 Middle East &amp; Africa Zoladex Market Value, By Application, 2021-2030 (US$ Million)

Table 31 Middle East &amp; Africa Zoladex Market Value, By Distribution Channel, 2021-2030 (US$ Million)

Table 32 Tersera Therapeutics: Overview

Table 33 Tersera Therapeutics: Product Portfolio

Table 34 Tersera Therapeutics: Key Developments

Table 35 Mithra Pharmaceuticals: Overview

Table 36 Mithra Pharmaceuticals: Product Portfolio

Table 37 Mithra Pharmaceuticals: Key Developments

Table 38 Alvogen: Overview

Table 39 Alvogen: Product Portfolio

Table 40 Alvogen: Key Developments

Table 41 AMW GmbH: Overview

Table 42 AMW GmbH: Product Portfolio

Table 43 AMW GmbH: Key Developments

Table 44 AstraZeneca Plc: Overview

Table 45 AstraZeneca Plc: Product Portfolio

Table 46 AstraZeneca Plc: Key Developments

Table 47 Luye Pharma: Overview

Table 48 Luye Pharma: Product Portfolio

Table 49 Luye Pharma: Key Developments

Table 50 Atossa Therapeutics: Overview

Table 51 Atossa Therapeutics: Product Portfolio

Table 52 Atossa Therapeutics: Key Developments

Table 53 Sanofi: Overview

Table 54 Sanofi: Product Portfolio

Table 55 Sanofi: Key Developments

Table 56 Fosun Pharma: Overview

Table 57 Fosun Pharma: Product Portfolio

Table 58 Fosun Pharma: Key Developments

Table 59 Bachem: Overview

Table 60 Bachem: Product Portfolio

Table 61 Bachem: Key Developments

<h3>&nbsp;</h3>

<h3>List of Figures</h3>

Figure 1 Global Zoladex Market Value, 2021-2030 (US$ Million)

Figure 2 Global Zoladex Market Share, By Dosage, 2022 &amp; 2030 (%)

Figure 3 Global Zoladex Market Share, By Application, 2022 &amp; 2030 (%)

Figure 4 Global Zoladex Market Share, By Distribution Channel, 2022 &amp; 2030 (%)

Figure 5 Global Zoladex Market Share, By Region, 2022 &amp; 2030 (%)

Figure 6 Global Zoladex Market Y-o-Y Growth, By Dosage, 2022-2030 (%)

Figure 7 3.6mg Zoladex Market Value, 2021-2030 (US$ Million)

Figure 8 10.8mg Zoladex Market Value, 2021-2030 (US$ Million)

Figure 9 Global Zoladex Market Y-o-Y Growth, By Application, 2022-2030 (%)

Figure 10 Prostate Cancer Application in Global Zoladex Market Value, 2021-2030 (US$ Million)

Figure 11 Breast Cancer Application in Global Zoladex Market Value, 2021-2030 (US$ Million)

Figure 12 Endometriosis Application in Global Zoladex Market Value, 2021-2030 (US$ Million)

Figure 13 Others Application in Global Zoladex Market Value, 2021-2030 (US$ Million)

Figure 14 Global Zoladex Market Y-o-Y Growth, By Distribution Channel, 2022-2030 (%)

Figure 15 Hospital Pharmacies Distribution Channel in Global Zoladex Market Value, 2021-2030 (US$ Million)

Figure 16 Retail Pharmacies Distribution Channel in Global Zoladex Market Value, 2021-2030 (US$ Million)

Figure 17 Online Pharmacies Distribution Channel in Global Zoladex Market Value, 2021-2030 (US$ Million)

Figure 18 Global Zoladex Market Y-o-Y Growth, By Region, 2022-2030 (%)

Figure 19 North America Zoladex Market Value, 2021-2030 (US$ Million)

Figure 20 Asia-Pacific Zoladex Market Value, 2021-2030 (US$ Million)

Figure 21 Europe Zoladex Market Value, 2021-2030 (US$ Million)

Figure 22 South America Zoladex Market Value, 2021-2030 (US$ Million)

Figure 23 Middle East and Africa Zoladex Market Value, 2021-2030 (US$ Million)

Figure 24 North America Zoladex Market Value, 2021-2030 (US$ Million)

Figure 25 North America Zoladex Market Share, By Dosage, 2022 &amp; 2030 (%)

Figure 26 North America Zoladex Market Share, By Application, 2022 &amp; 2030 (%)

Figure 27 North America Zoladex Market Share, By Distribution Channel, 2022 &amp; 2030 (%)

Figure 28 North America Zoladex Market Share, By Country, 2022 &amp; 2030 (%)

Figure 29 South America Zoladex Market Value, 2021-2030 (US$ Million)

Figure 30 South America Zoladex Market Share, By Dosage, 2022 &amp; 2030 (%)

Figure 31 South America Zoladex Market Share, By Application, 2022 &amp; 2030 (%)

Figure 32 South America Zoladex Market Share, By Distribution Channel, 2022 &amp; 2030 (%)

Figure 33 South America Zoladex Market Share, By Country, 2022 &amp; 2030 (%)

Figure 34 Europe Zoladex Market Value, 2021-2030 (US$ Million)

Figure 35 Europe Zoladex Market Share, By Dosage, 2022 &amp; 2030 (%)

Figure 36 Europe Zoladex Market Share, By Application, 2022 &amp; 2030 (%)

Figure 37 Europe Zoladex Market Share, By Distribution Channel, 2022 &amp; 2030 (%)

Figure 38 Europe Zoladex Market Share, By Country, 2022 &amp; 2030 (%)

Figure 39 Asia-Pacific Zoladex Market Value, 2021-2030 (US$ Million)

Figure 40 Asia-Pacific Zoladex Market Share, By Dosage, 2022 &amp; 2030 (%)

Figure 41 Asia-Pacific Zoladex Market Share, By Application, 2022 &amp; 2030 (%)

Figure 42 Asia-Pacific Zoladex Market Share, By Distribution Channel, 2022 &amp; 2030 (%)

Figure 43 Asia-Pacific Zoladex Market Share, By Country, 2022 &amp; 2030 (%)

Figure 44 Middle East &amp; Africa Zoladex Market Value, 2021-2030 (US$ Million)

Figure 45 Middle East &amp; Africa Zoladex Market Share, By Dosage, 2022 &amp; 2030 (%)

Figure 46 Middle East &amp; Africa Zoladex Market Share, By Application, 2022 &amp; 2030 (%)

Figure 47 Middle East &amp; Africa Zoladex Market Share, By Distribution Channel, 2022 &amp; 2030 (%)

Figure 48 Tersera Therapeutics: Financials

Figure 49 Mithra Pharmaceuticals: Financials

Figure 50 Alvogen: Financials

Figure 51 AMW GmbH: Financials

Figure 52 AstraZeneca Plc: Financials

Figure 53 Luye Pharma: Financials

Figure 54 Atossa Therapeutics: Financials

Figure 55 Sanofi: Financials

Figure 56 Fosun Pharma: Financials

Figure 57 Bachem: Financials

Zoladex Market Size, Share, Industry, Forecast and outlook (2023-2030)

Breast Cancer Drugs Market Size, Share, Industry, Forecast and outlook (2023-2030)

Published: 2023 July 25

Starting from

Prostate Cancer Market Size, Share, Industry, Forecast and outlook (2023-2030)

Published: 2023 October 19

Starting from

Endometriosis Drug Market Size, Share, Industry, Forecast and outlook (2023-2030)

Published: 2022 October 04

Starting from

GnRH Agonists and Antagonists Drugs for Endometriosis Market Size, Share, Industry, Forecast and outlook (2023-2030)

Published: 2023 September 27

Starting from

Metronidazole Capsule Market Size, Share, Industry, Forecast and outlook (2023-2030)

Published: 2023 October 05

Starting from

Chronic fatigue syndrome Market Size, Share, Industry, Forecast and outlook (2023-2030)

Published: 2023 August 10

Starting from